ninety-three percent of breast carcinomas , 85 % of mastopathic lesions not associated with a carcinoma , and 66 % of fibroadenomas showed positive reactions with commercial unabsorbed polyclonal anti-cea serum , which contained antibodies to nca , whereas incubation with monospecific anti-cea antiserum resulted in 42 % positivity in carcinomas and negativity in mastopathic lesions and fibroadenomas .
C0003241
antibodies
C0020960
antiserum